2,791
Views
129
CrossRef citations to date
0
Altmetric
Reviews

Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings

, &
Pages 623-643 | Received 06 Sep 2018, Accepted 19 Dec 2018, Published online: 14 Mar 2019

References

  • Compton WM, Han B, Jones CM, Blanco C, Hughes A. Marijuana use and use disorders in adults in the USA, 2002–14: analysis of annual cross-sectional surveys. Lancet Psychiatry. 2016;3(10):954–64. doi:10.1016/S2215-0366(16)30208-5.
  • Hasin DS, Saha TD, Kerridge BT, Goldstein RB, Chou SP, Zhang H, Jung J, Pickering RP, Ruan WJ, Smith SM, et al. Prevalence of marijuana use disorders in the United States between 2001–2002 and 2012–2013. JAMA Psychiatry. 2015;72(12):1235–42. doi:10.1001/jamapsychiatry.2015.1858.
  • Grucza RA, Agrawal A, Krauss MJ, Cavazos-Rehg PA, Bierut LJ. Recent trends in the prevalence of marijuana use and associated disorders in the United States. JAMA Psychiatry. 2016;73(3):300–01. doi:10.1001/jamapsychiatry.2015.3111.
  • Carliner H, Mauro PM, Brown QL, Shmulewitz D, Rahim-Juwel R, Al S, Wall MM, Martins SS, Carliner G, Hasin DS. The widening gender gap in marijuana use prevalence in the U.S. during a period of economic change, 2002–2014. Drug Alcohol Depend. 2017;170:51–58. doi:10.1016/j.drugalcdep.2016.10.042.
  • Kerr WC, Lui C, Ye Y. Trends and age, period and cohort effects for marijuana use prevalence in the 1984–2015 US National Alcohol Surveys. Addiction. 2018;113(3):473–81. doi:10.1111/add.14031.
  • Azofeifa A, Mattson ME, Schauer G, McAfee T, Grant A, Lyerla R. National estimates of marijuana use and related indicators: National Survey on Drug Use and Health, United States, 2002–2014. MMWR Surveill Summ. 2016;65(11):1–28. doi:10.15585/mmwr.ss6511a1.
  • Sofuoglu M, Sugarman DE, Carroll KM. Cognitive function as an emerging treatment target for marijuana addiction. Exp Clin Psychopharmacol. 2010;18(2):109–19. doi:10.1037/a0019295.
  • Volkow ND, Swanson JM, Evins AE, DeLisi LE, Meier MH, Gonzalez R. Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review. JAMA Psychiatry. 2016;73(3):292–97. doi:10.1001/jamapsychiatry.2015.3278.
  • Livne O, Shmulewitz D, Lev-Ran S, Hasin DS. DSM-5. cannabis withdrawal syndrome: demographic and clinical correlates in U.S. adults. Drug Alcohol Depend; 2018. :Oct 16. pii: S0376-8716(18)30714–2. doi:10.1016/j.drugalcdep.2018.09.005
  • Ghasemiesfe M, Ravi D, Vali M, Korenstein D, Arjomandi M, Frank J, Austin PC, Keyhani S. Marijuana use, respiratory symptoms, and pulmonary function: a systematic review and meta-analysis. Ann Intern Med. 2018;169(2):106–15. doi:10.7326/M18-0522.
  • Brady JE, Li G. Trends in alcohol and other drugs detected in fatally injured drivers in the United States, 1999–2010. Am J Epidemiol. 2014;179(6):692–99. doi:10.1093/aje/kwt327.
  • Rogeberg O, Elvik R. The effects of cannabis intoxication on motor vehicle collision revisited and revised. Addiction. 2016;111(8):1348–59. doi:10.1111/add.13347.
  • Asbridge M, Hayden JA, Cartwright JL. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ. 2012;344:e536. doi:10.1136/bmj.e536.
  • Li MC, Brady JE, DiMaggio CJ, Lusardi AR, Tzong KY, Li G. Marijuana use and motor vehicle crashes. Epidemiol Rev. 2012;34:65–72. doi:10.1093/epirev/mxr017.
  • Watson TM, Mann RE. International approaches to driving under the influence of cannabis: a review of evidence on impact. Drug Alcohol Depend. 2016;169:148–55. doi:10.1016/j.drugalcdep.2016.10.023.
  • Strand MC, Gjerde H, Morland J. Driving under the influence of non-alcohol drugs: an update. Part II: experimental Studies. Forensic Sci Rev. 2016;28(2):79–101.
  • Hartman RL, Huestis MA. Cannabis effects on driving skills. Clin Chem. 2013;59(3):478–92. doi:10.1373/clinchem.2012.194381.
  • Hartman RL, Brown TL, Milavetz G, Spurgin A, Pierce RS, Gorelick DA, Gaffney G, Huestis MA. Cannabis effects on driving lateral control with and without alcohol. Drug Alcohol Depend. 2015;154:25–37. doi:10.1016/j.drugalcdep.2015.06.015.
  • Lenne MG, Dietze PM, Triggs TJ, Walmsley S, Murphy B, Redman JR. The effects of cannabis and alcohol on simulated arterial driving: influences of driving experience and task demand. Accid Anal Prev. 2010;42(3):859–66. doi:10.1016/j.aap.2009.04.021.
  • Zhu H, Wu LT. Trends and correlates of cannabis-involved emergency department visits: 2004 to 2011. J Addict Med. 2016;10(6):429–36. doi:10.1097/ADM.0000000000000256.
  • Bollom A, Austrie J, Hirsch W, Nee J, Friedlander D, Iturrino J, Ballou S, Lembo A. Emergency department burden of nausea and vomiting associated with cannabis use disorder: us trends from 2006 to 2013. J Clin Gastroenterol. 2017. doi:10.1097/MCG.0000000000000944.
  • Richards JR. Cannabinoid hyperemesis syndrome: pathophysiology and treatment in the emergency department. J Emerg Med. 2018. doi:10.1016/j.jemermed.2017.12.010.
  • Hasin DS, O’Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, Compton WM, Crowley T, Ling W, Petry NM, et al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry. 2013;170(8):834–51. doi:10.1176/appi.ajp.2013.12060782.
  • Hasin DS, Kerridge BT, Saha TD, Huang B, Pickering R, Smith SM, Jung J, Zhang H, Grant BF. Prevalence and correlates of DSM-5 cannabis use disorder, 2012–2013: findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Am J Psychiatry. 2016;173(6):588–99. doi:10.1176/appi.ajp.2015.15070907.
  • Compton WM, Grant BF, Colliver JD, Glantz MD, Stinson FS. Prevalence of marijuana use disorders in the United States: 1991–1992 and 2001–2002. JAMA. 2004;291(17):2114–21. doi:10.1001/jama.291.17.2114.
  • Hasin DS. US epidemiology of cannabis use and associated problems. Neuropsychopharmacology. 2018;43(1):195–212. doi:10.1038/npp.2017.198.
  • Carliner H, Brown QL, Sarvet AL, Hasin DS. Cannabis use, attitudes, and legal status in the U.S.: A review. Prev Med. 2017;104:13–23.
  • Sarvet AL, Wall MM, Fink DS, Greene E, Le A, Boustead AE, Pacula RL, Keyes KM, Cerdá M, Galea S, et al. Medical marijuana laws and adolescent marijuana use in the United States: a systematic review and meta-analysis. Addiction. 2018;113(6):1003–16. doi:10.1111/add.14136.
  • Volkow ND, Compton WM, Wargo EM. The risks of marijuana use during pregnancy. JAMA. 2017;317(2):129–30. doi:10.1001/jama.2016.18612.
  • Saint Louis C A balm when you’re expecting: sometimes pot does the trick [Internet]. The New York Times; 2017 Feb 20. Available from: https://www.nytimes.com/2017/02/20/health/marijuana-pregnancy-mothers.html.
  • National Survey on Drug Use and Health. NSDUH [Internet]. Substance Abuse and Mental Health Services Administration; RTI International. [accessed 2018 April 15].  Available from: https://nsduhweb.rti.org/respweb/homepage.cfm.
  • Grant BF. Prevalence and correlates of alcohol use and DSM-IV alcohol dependence in the United States: results of the National Longitudinal Alcohol Epidemiologic Survey. J Stud Alcohol. 1997;58(5):464–73.
  • Grant BF. Prevalence and correlates of drug use and DSM-IV drug dependence in the United States: results of the National Longitudinal Alcohol Epidemiologic Survey. J Subst Abuse. 1996;8(2):195–210.
  • Grant BF, Moore TC, Shepard J, Kaplan K. Source and accuracy statement: wave 1 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Bethesda (MD): National Institute on Alcohol Abuse and Alcoholism, 2003.
  • Grant BF, Chu A, Sigman R, Amsbary M, Kali J, Sugawara Y, Jiao R, et al. Source and accuracy statement: National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III). Rockville (MD): National Institute on Alcohol Abuse and Alcoholism, 2014. Available from: https://www.niaaa.nih.gov/sites/default/files/NESARC_Final_Report_FINAL_1_8_15.pdf.
  • Alcohol Research Group. National alcohol surveys [Internet]. Emeryville (CA): Public Health Institute. 2018. Available from http://arg.org/center/national-alcohol-surveys/.
  • Johnston LD, O’Malley PM, Miech RA, Bachman JG, Schulenberg JE. Monitoring the future: national survey results on drug use, 1975–2016. Overview: key findings on adolescent drug use [Internet]. Ann Arbor (MI): Institute for Social Research, University of Michigan. 2017. Available from http://www.monitoringthefuture.org/pubs/monographs/mtf-overview2016.pdf.
  • Centers for Disease Control and Prevention. Adolescent and school health: youth risk behavior surveillance system (YRBSS) [Internet]. Atlanta (GA): U.S. Department of Health & Human Services. 2018. Available from https://www.cdc.gov/healthyyouth/data/yrbs/index.htm.
  • Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, Pickering RP, Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61(8):807–16. doi:10.1001/archpsyc.61.8.807.
  • Grant BF, Stinson FS, Dawson DA, Chou SP, Ruan WJ, Pickering RP. Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61(4):361–68. doi:10.1001/archpsyc.61.4.361.
  • Grant BF, Goldstein RB, Saha TD, Chou SP, Jung J, Zhang H, Pickering RP, Ruan WJ, Smith SM, Huang B, et al. Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry. 2015;72(8):757–66. doi:10.1001/jamapsychiatry.2015.0584.
  • Substance Abuse and Mental health services administration. Results from the 2012 National Survey on Drug Use and Health: Summary of national findings. Appendix B: Statistical methods and measurement. Rockville (MD):U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality; 2013. NSDUH Series H-46, HHS Publication No. (SMA) 13–4795. [accessed 2018 November 29]. Available from: https://www.samhsa.gov/data/sites/default/files/NSDUHresults2012/NSDUHresults2012.pdf.
  • Adams PF, Kirzinger WK, Martinez M. Summary health statistics for the U.S. population: National Health Interview Survey, 2012. Vital Health Stat. 2013;10(259):1–95.
  • Grant BF, Goldstein RB, Chou SP, Saha TD, Ruan WJ, Huang B, Smith SM, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-Diagnostic and Statistical Manual of Mental Disorders. fifth edition. version (AUDADIS-5) Rockville (MD): National Institute on Alcohol Abuse and Alcoholism. 2011.
  • Grant BF, Dawson DA, Hasin DS. The alcohol use disorder and associated disabilities interview schedule-DSM-IV version. Bethesda (MD): National Institute on Alcohol Abuse and Alcoholism; 2001.
  • Hasin DS, Al S, Cerda M, Km K, Stohl M, Galea S, Wall MM. US adult illicit cannabis use, cannabis use disorder, and medical marijuana laws: 1991–1992 to 2012–2013. JAMA Psychiatry. 2017;74(6):579–88. doi:10.1001/jamapsychiatry.2017.0724.
  • Canino G, Bravo M, Ramírez R, Febo VE, Rubio-Stipec M, Fernández RL, Hasin D. The spanish Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability and concordance with clinical diagnoses in a Hispanic population. J Stud Alcohol. 1999;60(6):790–99.
  • Chatterji S, Saunders JB, Vrasti R, Grant BF, Hasin D, Mager D. Reliability of the Alcohol Use Disorder and Associated Disabilities Interview Schedule-alcohol/drug-revised (AUDADIS-ADR): an international comparison. Drug Alcohol Depend. 1997;47(3):171–85.
  • Cottler LB, Grant BF, Blaine J, Mavreas V, Pull C, Hasin D, Compton WM, Rubio-Stipec M, Mager D. Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN. Drug Alcohol Depend. 1997;47(3):195–205.
  • Grant BF. DSM-IV, DSM-III-R, and ICD-10 alcohol and drug abuse/harmful use and dependence, United States, 1992: a nosological comparison. Alcohol Clin Exp Res. 1996;20(8):1481–88.
  • Grant BF, Dawson DA, Stinson FS, Chou PS, Kay W, Pickering R. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 2003;71(1):7–16.
  • Grant BF, Harford TC, Dawson DA, Chou PS, Pickering RP. The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample. Drug Alcohol Depend. 1995;39(1):37–44.
  • Hasin D, Carpenter KM, McCloud S, Smith M, Grant BF. The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample. Drug Alcohol Depend. 1997;44(2–3):133–41.
  • Hasin D, Grant BF, Cottler L, Blaine J, Towle L, Ustun B, Sartorius N. Nosological comparisons of alcohol and drug diagnoses: a multisite, multi-instrument international study. Drug Alcohol Depend. 1997;47(3):217–26.
  • Nelson CB, Rehm J, Ustun TB, Grant B, Chatterji S. Factor structures for DSM-IV substance disorder criteria endorsed by alcohol, cannabis, cocaine and opiate users: results from the WHO reliability and validity study. Addiction. 1999;94(6):843–55.
  • Pull CB, Saunders JB, Mavreas V, Cottler LB, Grant BF, Hasin DS, Blaine J, Mager D, Ustün BT. Concordance between ICD-10 alcohol and drug use disorder criteria and diagnoses as measured by the AUDADIS-ADR, CIDI and SCAN: results of a cross-national study. Drug Alcohol Depend. 1997;47(3):207–16.
  • Ustun B, Compton W, Mager D, Babor T, Baiyewu O, Chatterji S, Cottler L, Göğüş A, Mavreas V, Peters L, et al. WHO study on the reliability and validity of the alcohol and drug use disorder instruments: overview of methods and results. Drug Alcohol Depend. 1997;47(3):161–69.
  • Vrasti R, Grant BF, Chatterji S, Ustun BT, Mager D, Olteanu I, Badoi M. Reliability of the romanian version of the alcohol module of the WHO Alcohol Use Disorder and Associated Disabilities Interview Schedule-alcohol/drug-revised. Eur Addict Res. 1998;4(4):144–49. doi:10.1159/000018947.
  • Grant BF, Harford TC, Dawson DA, Dufour M, Pickering R, Chou P. Prevalence of DSM-IV alcohol abuse and dependence: united States, 1992. Alcohol Health Res World. 1994;18(3):243–48.
  • Grant BF, Goldstein RB, Smith SM, Jung J, Zhang H, Chou SP, Pickering RP, Ruan WJ, Huang B, Saha TD, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): reliability of substance use and psychiatric disorder modules in a general population sample. Drug Alcohol Depend. 2015;148:27–33. doi:10.1016/j.drugalcdep.2014.11.026.
  • Hasin DS, Greenstein E, Aivadyan C, Stohl M, Aharonovich E, Saha T, Goldstein R, Nunes EV, Jung J, Zhang H, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample. Drug Alcohol Depend. 2015;148:40–46. doi:10.1016/j.drugalcdep.2014.12.011.
  • Martins SS, Sarvet A, Santaella-Tenorio J, Saha T, Grant BF, Hasin DS. Changes in US lifetime heroin use and heroin use disorder: prevalence from the 2001–2002 to 2012–2013 National Epidemiologic Survey on Alcohol and Related Conditions. JAMA Psychiatry. 2017;74(5):445–55. doi:10.1001/jamapsychiatry.2017.0113.
  • Grant BF, Chou SP, Saha TD, Pickering RP, Kerridge BT, Ruan WJ, Huang B, Jung J, Zhang H, Fan A, et al. Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001–2002 to 2012–2013: results from the National Epidemiologic Survey on Alcohol and Related Conditions. JAMA Psychiatry. 2017;74(9):911–23. doi:10.1001/jamapsychiatry.2017.2161.
  • Saha TD, Kerridge BT, Goldstein RB, Chou SP, Zhang H, Jung J, Pickering RP, Ruan WJ, Smith SM, Huang B, et al. Nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder in the United States. J Clin Psychiatry. 2016;77(6):772–80. doi:10.4088/JCP.15m10386.
  • Research Triangle Institute. SUDAAN, release 11.0.1 [software]. RTI International: Research Triangle Park (NC).
  • Shi Y, Zhong S. Trends in cannabis use disorder among pregnant women in the U.S., 1993–2014. J Gen Intern Med. 2018;33(3):245–46. doi:10.1007/s11606-017-4201-0.
  • Glazier RE, Kling RN. Recent trends in substance abuse among persons with disabilities compared to that of persons without disabilities. Disabil Health J. 2013;6(2):107–15. doi:10.1016/j.dhjo.2013.01.007.
  • Kerr WC, Greenfield TK, Bond J, Ye Y, Rehm J. Age-period-cohort influences on trends in past year marijuana use in the US from the 1984, 1990, 1995 and 2000 National Alcohol Surveys. Drug Alcohol Depend. 2007;86(2–3):132–38. doi:10.1016/j.drugalcdep.2006.05.022.
  • Centers for Disease Control and Prevention. International Classification of Diseases, ninth revision, clinical modification (ICD-9-CM) [Internet]. 2013 June 18. [accessed 2018 November 21].  Available from: https://www.cdc.gov/nchs/icd/icd9cm.htm.
  • Bonn-Miller MO, Harris AH, Trafton JA. Prevalence of cannabis use disorder diagnoses among veterans in 2002, 2008, and 2009. Psychol Serv. 2012;9(4):404–16. doi:10.1037/a0027622.
  • Gubatan J, Staller K, Barshop K, Kuo B. Cannabis abuse Is increasing and associated with increased emergency department utilization in gastroenterology patients. Dig Dis Sci. 2016;61(7):1844–52. doi:10.1007/s10620-016-4090-9.
  • Charilaou P, Agnihotri K, Garcia P, Badheka A, Frenia D, Yegneswaran B. Trends of cannabis use disorder in the inpatient: 2002 to 2011. Am J Med. 2017;130(6):678–87 e7. doi:10.1016/j.amjmed.2016.12.035.
  • Shi Y. Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever. Drug Alcohol Depend. 2017;173:144–50. doi:10.1016/j.drugalcdep.2017.01.006.
  • McKay MP, Groff L. 23 years of toxicology testing fatally injured pilots: implications for aviation and other modes of transportation. Accid Anal Prev. 2016;90:108–17. doi:10.1016/j.aap.2016.02.008.
  • Hasin DS, Grant B. NESARC findings on increased prevalence of marijuana use disorders: consistent with other sources of information. JAMA Psychiatry. 2016;73(5):532. doi:10.1001/jamapsychiatry.2015.2123.
  • Mauro PM, Carliner H, Brown QL, Hasin DS, Shmulewitz D, Rahim R, Sarvet AL, Wall MM, Martins SS. Age differences in daily and nondaily cannabis use in the United States, 2002–2014. J Stud Alcohol Drugs. 2018;79(3):423–31.
  • Wu LT, Zhu H, Swartz MS. Trends in cannabis use disorders among racial/ethnic population groups in the United States. Drug Alcohol Depend. 2016;165:181–90. doi:10.1016/j.drugalcdep.2016.06.002.
  • Brown QL, Al S, Shmulewitz D, Ss M, Mm W, Ds H. Trends in marijuana use among pregnant and nonpregnant reproductive-aged women, 2002–2014. JAMA. 2017;317(2):207–09. doi:10.1001/jama.2016.17383.
  • Han BH, Sherman S, Mauro PM, Martins SS, Rotenberg J, Palamar JJ. Demographic trends among older cannabis users in the United States, 2006–13. Addiction. 2017;112(3):516–25. doi:10.1111/add.13670.
  • Salas-Wright CP, Vaughn MG, Cummings-Vaughn LA, Holzer KJ, Nelson EJ, AbiNader M. Trends and correlates of marijuana use among late middle-aged and older adults in the United States, 2002–2014. Drug Alcohol Depend. 2017;171:97–106. doi:10.1016/j.drugalcdep.2016.11.031.
  • Grucza RA, Agrawal A, Krauss MJ, Bongu J, Plunk AD, Cavazos-Rehg PA. Declining prevalence of marijuana use disorders among adolescents in the United States, 2002 to 2013. J Am Acad Child Adolesc Psychiatry. 2016;55(6):487–94 e6. doi:10.1016/j.jaac.2016.04.002.
  • Han B, Compton WM, Jones CM, Blanco C. Cannabis use and cannabis use disorders among youth in the United States, 2002–2014. J Clin Psychiatry. 2017;78(9):1404–13. doi:10.4088/JCP.16m10948.
  • Miech R, Johnston L, O’Malley PM. Prevalence and attitudes regarding marijuana use among adolescents over the past decade. Pediatrics. 2017;140:6. doi:10.1542/peds.2017-0685.
  • Johnson RM, Fairman B, Gilreath T, Xuan Z, Rothman EF, Parnham T, Furr-Holden CDM. Past 15-year trends in adolescent marijuana use: differences by race/ethnicity and sex. Drug Alcohol Depend. 2015;155:8–15. doi:10.1016/j.drugalcdep.2015.08.025.
  • Salas-Wright CP, Vaughn MG, Todic J, Cordova D, Perron BE. Trends in the disapproval and use of marijuana among adolescents and young adults in the United States: 2002–2013. Am J Drug Alcohol Abuse. 2015;41(5):392–404. doi:10.3109/00952990.2015.1049493.
  • Monitoring the Future. Table 2: trends in annual prevalence of use of various drugs in grades 8, 10, and 12 [Internet]. Ann Arbor (MI): University of Michigan;2018.  Available from http://www.monitoringthefuture.org/data/17data/17drtbl2.pdf.
  • Pacek LR, Mauro PM, Martins SS. Perceived risk of regular cannabis use in the United States from 2002 to 2012: differences by sex, age, and race/ethnicity. Drug Alcohol Depend. 2015;149:232–44. doi:10.1016/j.drugalcdep.2015.02.009.
  • Johnston LD, O’Malley PM, Miech RA, Bachman JG, Schulenberg JE. Demographic subgroup trends among adolescents in the use of various licit and illicit drugs, 1975–2016 [Internet]. Ann Arbor (MI): Institute for Social Research, University of Michigan. 2017. Available from http://www.monitoringthefuture.org/pubs/occpapers/mtf-occ88.pdf.
  • Lanza ST, Vasilenko SA, Dziak JJ, Butera NM. Trends among U.S. high school seniors in recent marijuana use and associations with other substances: 1976–2013. J Adolesc Health. 2015;57(2):198–204. doi:10.1016/j.jadohealth.2015.04.006.
  • Miech RA, Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE, Patrick ME. Monitoring the Future national survey results on drug use, 1975–2017: volume I, secondary school students. Ann Arbor (MI): Institute for Social Research, University of Michigan. 2018. Available from http://monitoringthefuture.org/pubs/monographs/mtf-vol1_2017.pdf.
  • Keyes KM, Wall M, Feng T, Cerda M, Hasin DS. Race/ethnicity and marijuana use in the United States: diminishing differences in the prevalence of use, 2006–2015. Drug Alcohol Depend. 2017;179:379–86. doi:10.1016/j.drugalcdep.2017.07.027.
  • Wilkinson ST, van Schalkwyk GI, Davidson L, D’Souza DC. The formation of marijuana risk perception in a population of substance abusing patients. Psychiatr Q. 2016;87(1):177–87. doi:10.1007/s11126-015-9369-z.
  • Al S, Mm W, Km K, Cerda M, Je S, Pm O, Johnston LD, Hasin DS. Recent rapid decrease in adolescents’ perception that marijuana is harmful, but no concurrent increase in use. Drug Alcohol Depend. 2018;186:68–74. doi:10.1016/j.drugalcdep.2017.12.041.
  • Cerda M, Wall M, Keyes KM, Galea S, Hasin D. Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence. Drug Alcohol Depend. 2012;120(1–3):22–27. doi:10.1016/j.drugalcdep.2011.06.011.
  • Martins SS, Mauro CM, Santaella-Tenorio J, Kim JH, Cerda M, Keyes KM, Hasin DS, Galea S, Wall M. State-level medical marijuana laws, marijuana use and perceived availability of marijuana among the general U.S. Population Drug Alcohol Depend. 2016;169:26–32. doi:10.1016/j.drugalcdep.2016.10.004.
  • Wen H, Hockenberry JM, Cummings JR. The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances. J Health Econ. 2015;42:64–80. doi:10.1016/j.jhealeco.2015.03.007.
  • Kerridge BT, Chou SP, Pickering RP, Ruan WJ, Huang B, Jung J, Zhang H, Fan AZ, Saha TD, Grant BF, et al. Changes in the prevalence and correlates of cocaine use and cocaine use disorder in the United States, 2001–2002 and 2012–2013. Addict Behav. 2018;90:250–57. doi:10.1016/j.addbeh.2018.11.005.
  • Mital S, Windle M, Cooper HLF, Crawford ND. Trends in non-medical prescription opioids and heroin co-use among adults, 2003–2014. Addict Behav. 2018;86:17–23. doi:10.1016/j.addbeh.2018.05.005.
  • Cheng HG, Anthony JC. A new era for drinking? Epidemiological evidence on adolescent male-female differences in drinking incidence in the United States and Europe. Soc Psychiatry Psychiatr Epidemiol. 2017;52(1):117–26. doi:10.1007/s00127-016-1318-0.
  • Miech RA, Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE, Patrick ME. Monitoring the Future national survey results on drug use, 1975–2016: volume I, secondary school students. Ann Arbor (MI): Institute for Social Research, University of Michigan. 2017. Available from http://www.monitoringthefuture.org/pubs/monographs/mtf-vol1_2016.pdf.
  • Martins SS, Segura LE, Santaella-Tenorio J, Perlmutter A, Fenton MC, Cerda M, Keyes KM, Ghandour LA, Storr CL, Hasin DS. Prescription opioid use disorder and heroin use among 12–34 year-olds in the United States from 2002 to 2014. Addict Behav. 2017;65:236–41. doi:10.1016/j.addbeh.2016.08.033.
  • National Center for HIV/AIDS VH, STD, and TB Prevention. Trends in the prevalence of marijuana, cocaine, and other illegal drug use, national YRBS: 1991–2015 [Internet]. Centers for Disease Control and Prevention. [accessed 2018 April 25]. Available from: https://www.cdc.gov/healthyyouth/data/yrbs/pdf/trends/2015_us_drug_trend_yrbs.pdf.
  • Keyes KM, Gary DS, Beardslee J, Prins SJ, O’Malley PM, Rutherford C, Schulenberg J. Joint effects of age, period, and cohort on conduct problems among American adolescents from 1991 through 2015. Am J Epidemiol. 2018;187(3):548–57. doi:10.1093/aje/kwx268.
  • Centers for Disease Control and Prevention. Trends in the prevalence of suicide-related behavior, national YRBS: 1991–2015 [Internet]. Division of adolescent and school health, national center for HIV/AIDS. Viral Hepatitis, STD, and TB Prevention. [accessed 2018 November 29]. Available from https://www.cdc.gov/healthyyouth/data/yrbs/pdf/trends/2015_us_suicide_trend_yrbs.pdf.
  • Curtin SC, Warner M, Hedegaard H. Increase in suicide in the United States, 1999–2014. NCHS Data Brief. 2016;241:1–8.
  • Twenge JM, Campbell WK. Associations between screen time and lower psychological well-being among children and adolescents: evidence from a population-based study. Prev Med Rep. 2018;12:271–83. doi:10.1016/j.pmedr.2018.10.003.
  • Han B, Compton WM, Blanco C, Jones CM. Trends in and correlates of medical marijuana use among adults in the United States. Drug Alcohol Depend. 2018;186:120–29. doi:10.1016/j.drugalcdep.2018.01.022.
  • Wall MM, Olfson M, Hasin D, Liu J, Blanco C. Use of marijuana exclusively for medical purposes. Drug Alcohol Depend. in press. 2018 Dec 4;195:13–15. doi:10.1016/j.drugalcdep.2018.11.009.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.